Skip to main content

Table 1 Baseline characteristics of the older men and women with (T2D Yes) and without type 2 diabetes (T2D No) included in this study

From: Similar decline in mortality rate of older persons with and without type 2 diabetes between 1993 and 2004 the Icelandic population-based Reykjavik and AGES-Reykjavik cohort studies

 

Men

Women

Variable

Reykjavik Study

AGES-Reykjavik

Reykjavik Study

AGES-Reykjavik

 

1993

2004

1993

2004

Mean ± SD, IQR or%

T2D No

T2D Yes

T2D No

T2D Yes

T2D No

T2D Yes

T2D No

T2D Yes

Number

530

106

1738

330

792

78

2471

275

Age, years

74.7 (±3.5)

74.1 (±3.3) *

77.0 (±4.5)

77.1 (±4.4)

75.3 (±3.6)

75.7 (±4.1)

77.3 (±4.7)

77.9 (±4.5)*

Total cholesterol, mmol/l

6.01 (±1.05)

5.91 (±1.12)

5.23 (±1.07)

4.92 (±1.12) ***

7.03 (±1.25)

6.97 (±1.18)

6.00 (±1.10)

5.53 (±1.13) ***

HDL cholesterol, mmol/l

1.14 (±0.31)

1.05 (± 0.35) *

1.42 (±0.40)

1.25 (±0.32) ***

1.52 (±0.41)

1.34 (±0.47) ***

1.74 (±0.44)

1.52 (±0.43) **

TG mmol/l, median (IQR)

1.07 (±0.61)

1.43 (1.05) ***

0.98 (0.57)

1.30 (0.88) ***

1.21 (0.66)

1.80 (1.30) ***

1.05 (0.64)

1.40 (0.84) ***

CRP mg/l, median (IQR)

-

-

1.80 (2.60)

1.90 (2.70)

-

-

1.90 (2.90)

2.80 (4.60)

BMI, kg/m2

25.9 (±3.6)

27.5 (±3.9) ***

26.5 (±3.7)

28.4 (±4.1) ***

26.2 (±4.5)

29.1 (±6.1) ***

26.9 (±4.7)

29.5 (±5.2) ***

Systolic BP, mm Hg

150 (±22)

159 (± 26) **

142 (±20)

145 (±21) *

148 (±21)

152 (±19)

142 (±21)

144 (±21)

Diastolic BP, mm Hg

85 (±10)

88 (± 11) **

76 (±11)

75 (±11) **

80 (±10)

81 (± 11)

72 (± 9)

70 (±10) **

Hypertension (%)a

79.2

85.8

77.8

91.1

75.0

85.9

81.3

91.9 ***

Hypertensive medication (%)

26.8

35.8

59.2

79.7***

34.8

48.7*

63.8

83.8 ***

Lipid-lowering medication (%)

1.9

2.8

27.3

37.7

2.0

0

17.7

37.0***

Prevalence of CHD (%)b

17.4

17.0

24.8

31.8**

4.6

5.1

8.3

14.0*

Prevalence of MI (%)c

13.4

13.2

12.4

14.6

3.9

3.9

4.6

7.6

Family history of MI (%)

26.0

21.7

34.1

37.7**

29.3

32.1

42.6

49.8 **

Current smoker (%)

17.6

20.8

11.0

9.2

17.6

11.5

12.5

9.8

Haemoglobin A1c (%)

-

-

5.55 (±0.31)

6.44 (±0.83) ***

-

-

5.61 (±0.32)

6.42 (±0.88) ***

Glucose, mmol/l

5.77 (±0.48)

8.16 (±2.01) ***

5.58 (±0.51)

7.91 (±2.16) ***

5.51 (±0.56)

7.79 (±2.24) ***

5.43 (±0.51)

7.73 (±2.09) ***

  1. Significance estimates: *p < .05; **p < .01; *** p < .001 for age-adjusted comparison between the Reykjavik Study and the AGES- Reykjavik Study.
  2. aHypertension, those with systolic BP > 140 mmHg, diastolic BP > 90 mm Hg or on hypertensive medication.
  3. bPrevalence of CHD, from hospital records, of those with history of myocardial infarction (MI), percutaneous coronary intervention, and coronary-artery bypass grafting.
  4. cPrevalence of MI, from hospital records, of those with history of MI.
  5. BMI: body mass index; BP: blood pressure; CHD: coronary heart disease; CRP: C-reactive protein; TG: triglyceride.
Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us